Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Tricoli

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Current Problems in Cancer|March 28, 2017
Pediatric oncology enters an era of precision medicineNita L Seibel, Katherine Janeway, Carl E Allen, et al.
International Journal of Sports Medicine|October 10, 2012
Molecular adaptations to concurrent trainingE O de Souza, V Tricoli, H Roschel, et al.
Cancer|February 6, 2016
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaJames V Tricoli, Donald G Blair, Carey K Anders, et al.
Oncology (Williston Park, N.Y.)|April 16, 1999
Prostate cancer risk assessment program. A model for the early detection of prostate cancerD W Bruner, A Baffoe-Bonnie, S Miller, et al.
Cancer|February 6, 2016
Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the futureAshley Wilder Smith, Nita L Seibel, Denise R Lewis, et al.
Cancer|December 2, 2017
A mutational comparison of adult and adolescent and young adult (AYA) colon cancerJames V Tricoli, Lisa A Boardman, Rajesh Patidar, et al.
BMC Medicine|November 16, 2013
Criteria for the use of omics-based predictors in clinical trials: explanation and elaborationLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Nature|October 18, 2013
Criteria for the use of omics-based predictors in clinical trialsLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1KCarolyn K McCourt, Zihan Wei, Kevin Kalinsky, et al.
JCO Precision Oncology|February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1ENeal Akhave, Zihe Song, David S Hong, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Current Problems in Cancer|March 28, 2017
Pediatric oncology enters an era of precision medicineNita L Seibel, Katherine Janeway, Carl E Allen, et al.
International Journal of Sports Medicine|October 10, 2012
Molecular adaptations to concurrent trainingE O de Souza, V Tricoli, H Roschel, et al.
Cancer|February 6, 2016
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaJames V Tricoli, Donald G Blair, Carey K Anders, et al.
Oncology (Williston Park, N.Y.)|April 16, 1999
Prostate cancer risk assessment program. A model for the early detection of prostate cancerD W Bruner, A Baffoe-Bonnie, S Miller, et al.
Cancer|February 6, 2016
Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the futureAshley Wilder Smith, Nita L Seibel, Denise R Lewis, et al.
Cancer|December 2, 2017
A mutational comparison of adult and adolescent and young adult (AYA) colon cancerJames V Tricoli, Lisa A Boardman, Rajesh Patidar, et al.
BMC Medicine|November 16, 2013
Criteria for the use of omics-based predictors in clinical trials: explanation and elaborationLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Nature|October 18, 2013
Criteria for the use of omics-based predictors in clinical trialsLisa M McShane, Margaret M Cavenagh, Tracy G Lively, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2025
Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1KCarolyn K McCourt, Zihan Wei, Kevin Kalinsky, et al.
JCO Precision Oncology|February 20, 2026
Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1ENeal Akhave, Zihe Song, David S Hong, et al.
Pageof 8